deltatrials

Pancreatic neoplasms Trials in Houston, United States

Conditions / Pancreatic neoplasms / Houston, United States

Clinical trials for Pancreatic neoplasms investigate a range of treatment strategies and patient populations.

19 total trials for this combination

Showing top 10 of 19 trials

Trials

NCT ID Title Status Phase
NCT05736731 A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression ACTIVE_NOT_RECRUITING PHASE1/PHASE2
NCT00363051 Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy COMPLETED PHASE2
NCT03685591 PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors TERMINATED PHASE1
NCT02950064 A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations UNKNOWN PHASE1
NCT01964430 Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the Apact Study) COMPLETED PHASE3
NCT04644315 A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors TERMINATED PHASE2
NCT00841191 A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors COMPLETED PHASE1/PHASE2
NCT05512377 Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder COMPLETED PHASE2
NCT04075305 The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study RECRUITING
NCT02301143 Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) COMPLETED PHASE2

Related Pages